A significant increase in the CD3+CXCR3+ cell subpopulation was found in RRMS patients after 7 and 14 days in culture, relative to ex vivo cells (p=0.018 and p=0.014, respectively). The gene discussed is CXCR3; the disease is relapsing-remitting multiple sclerosis.